Montreal, Canada

Mai Nguyen

This inventor holds 4 USPTO granted patents. Top assignees: Mcgill University, University of California. Active years: 2003-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mai Nguyen. Retrieved from https://idiyas.com/inventor/mai-nguyen-0wow1ter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Quebec, CA (2003)
  • Montreal, CA (2018 - 2020)

Company Filing History:


Years Active: 2003-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mai Nguyen: Innovator in Cancer Treatment

Introduction

Mai Nguyen is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of cancer research, particularly through her innovative work on MCL-1 antagonists. With a total of 4 patents to her name, Nguyen is recognized for her dedication to advancing medical science.

Latest Patents

Nguyen's latest patents focus on MCL-1 antagonists. These compositions and methods are designed to treat cancer effectively. The patents detail the use of MCL-1 antagonists in various therapeutic applications, showcasing her commitment to improving cancer treatment options.

Career Highlights

Throughout her career, Mai Nguyen has worked with esteemed institutions such as the University of California and McGill University. Her research has been pivotal in understanding the mechanisms of cancer and developing new treatment strategies.

Collaborations

Nguyen has collaborated with notable colleagues, including Gordon C. Shore and Patrick Harran. These partnerships have enriched her research and contributed to her success in the field.

Conclusion

Mai Nguyen's innovative work in cancer treatment through her patents on MCL-1 antagonists highlights her as a leading figure in medical research. Her contributions continue to inspire advancements in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…